Evidence map›Paper›PMID 29628341›Full record

ArticleEBioMedicine2018

The Human Cytomegalovirus Strain DB Activates Oncogenic Pathways in Mammary Epithelial Cells.

Amit Kumar, Manoj Kumar Tripathy, Sébastien Pasquereau, Fatima Al Moussawi, Wasim Abbas, Laurie Coquard, Kashif Aziz Khan, Laetitia Russo, Marie-Paule Algros, Séverine Valmary-Degano and 3 more

Open access · goldAbstract read
In one paragraph

Article in EBioMedicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
5.2field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Detection of Human CytomegalovirusThe journal of histochemistry and cytochemistry : official journal of the Histochemistry Society · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Cancers · 2025
    Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 2 countries.

Amit KumarDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France.
Manoj Kumar TripathyDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France.
Sébastien PasquereauDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France. Electronic address: sebastien.pasquereau@univ-fcomte.fr.
Fatima Al MoussawiDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France; Lebanese University, Beyrouth, Lebanon.
Wasim AbbasApex Biosolutions, F-25000 Besançon, France.
Laurie CoquardDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France.
Kashif Aziz KhanDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France.
Laetitia RussoDepartment of Pathology, CHRU Besançon, F-25030 Besançon, France.
Marie-Paule AlgrosDepartment of Pathology, CHRU Besançon, F-25030 Besançon, France. Electronic address: mp1algros@chu-besancon.fr.
Séverine Valmary-DeganoDepartment of Pathology, CHRU Besançon, F-25030 Besançon, France. Electronic address: sdeganovalmary@chu-besancon.fr.
Olivier AdoteviINSERM UMR1098, University of Bourgogne Franche-Comté, Besançon, France; Department of Medical Oncology, CHRU Besancon, F-25030 Besancon, France. Electronic address: Olivier.adotevi@univ-fcomte.fr.
Stéphanie Morot-BizotApex Biosolutions, F-25000 Besançon, France. Electronic address: smorot@apexlabo.com.
Georges HerbeinDepartment Pathogens & Inflammation-EPILAB, UPRES EA4266, University of Franche-Comté (UFC), University of Bourgogne France-Comté (UBFC), F-25030 Besançon, France; Department of Virology, CHRU Besancon, F-25030 Besancon, France. Electronic address: georges.herbein@univ-fcomte.fr.
Université de franche-comté · FRCentre Hospitalier Universitaire de Besançon · FRUniversité Bourgogne Franche-Comté · FRIDEXX Laboratories (France) · FRInserm · FRLebanese University · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHuman cytomegalovirus (HCMV) establishes a persistent life-long infection and increasing evidence indicates HCMV infection can modulate signaling pathways associated with oncogenesis. Breast milk is an important route of HCMV transmission in humans and we hypothesized that mammary epithelial cells could be one of the main cellular targets of HCMV infection.

methodsThe infectivity of primary human mammary epithelial cells (HMECs) was assessed following infection with the HCMV-DB strain, a clinical isolate with a marked macrophage-tropism. The impact of HCMV-DB infection on expression of p53 and retinoblastoma proteins, telomerase activity and oncogenic pathways (c-Myc, Akt, Ras, STAT3) was studied. Finally the transformation of HCMV-DB infected HMECs was evaluated using soft agar assay. CTH cells (CMV Transformed HMECs) were detected in prolonged cultures of infected HMECs. Tumor formation was observed in NOD/SCID Gamma (NSG) mice injected with CTH cells. Detection of long non coding RNA4.9 (lncRNA4.9) gene was assessed in CTH cells, tumors isolated from xenografted NSG mice and biopsies of patients with breast cancer using qualitative and quantitative PCR.

resultsWe found that HCMV, especially a clinical strain named HCMV-DB, infects HMECs in vitro. The clinical strain HCMV-DB replicates productively in HMECs as evidenced by detection of early and late viral transcripts and proteins. Following infection of HMECs with HCMV-DB, we observed the inactivation of retinoblastoma and p53 proteins, the activation of telomerase activity, the activation of the proto-oncogenes c-Myc and Ras, the activation of Akt and STAT3, and the upregulation of cyclin D1 and Ki67 antigen. Colony formation was observed in soft agar seeded with HCMV-DB-infected HMECs. Prolonged culture of infected HMECs resulted in the development of clusters of spheroid cells that we called CTH cells (CMV Transformed HMECs). CTH cells when injected in NOD/SCID Gamma (NSG) mice resulted in the development of tumors. We detected in CTH cells the presence of a HCMV signature corresponding to a sequence of the long noncoding RNA4.9 (lncRNA4.9) gene. We also found the presence of the HCMV lncRNA4.9 sequence in tumors isolated from xenografted NSG mice injected with CTH cells and in biopsies of patients with breast cancer using qualitative and quantitative PCR.

conclusionsOur data indicate that key molecular pathways involved in oncogenesis are activated in HCMV-DB-infected HMECs that ultimately results in the transformation of HMECs in vitro with the appearance of CMV-transformed HMECs (CTH cells) in culture. CTH cells display a HCMV signature corresponding to a lncRNA4.9 genomic sequence and give rise to fast growing triple-negative tumors in NSG mice. A similar lncRNA4.9 genomic sequence was detected in tumor biopsies of patients with breast cancer.

Indexed as

AnimalsBreastCarcinogenesisCell AggregationCell ProliferationCells, CulturedCell Transformation, NeoplasticColony-Forming Units AssayCyclin D1CytomegalovirusCytomegalovirus InfectionsEpithelial CellsFemaleHumansMice, Inbred NODMice, SCIDCCND1 protein, humanCyclin D1Proto-Oncogene Proteins c-aktRNA, Long NoncodingRNA, MessengerSTAT3 Transcription FactorTelomeraseTumor Suppressor Protein p53Viral ProteinsCTH cellsCytomegalovirusHCMVHCMV-DBHMECslncRNA4.9OncogenesisTransformation

Identifiers

PMID29628341
PMCPMC5952350
OpenAlexW2794777935

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.